Skip to main content

Andrology and endocrinology · London

Testosterone replacement therapy (TRT) - private in London.

TRT for men with biochemically confirmed hypogonadism, worked up and monitored to BSSM 2022 standards. Not a wellness product, not a lifestyle add-on. A prescribed medicine with a workup, a monitoring schedule and a set of contraindications that matter.

WhatsApp us
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

What TRT is

Testosterone replacement for confirmed hypogonadism.

Diagnosis rests on two morning samples plus consistent symptoms, per the British Society for Sexual Medicine (BSSM) 2022 guidelines.

Testosterone replacement therapy replaces the androgen that a man's own testes or pituitary can no longer produce in adequate amounts. It is a prescribed medicine, not a supplement. The diagnostic threshold in the UK is a total testosterone repeatedly below 8 nmol/L in the presence of consistent symptoms, or between 8 and 12 nmol/L when a low calculated free testosterone and symptoms both point to hypogonadism.

The BSSM 2022 guideline is the reference standard in UK private practice. It requires two early-morning fasted samples on separate days, an assessment of pituitary function, and a search for reversible causes before starting therapy. TRT that skips these steps is not clinical care.

Symptoms of low testosterone

When symptoms and biochemistry line up.

Symptoms alone do not diagnose hypogonadism. They point to where to look and give the biochemistry its meaning.

  • Persistent fatigue

    Not one bad week, but months of low energy that sleep does not repair.

  • Low libido

    A sustained drop in sexual interest rather than a transient dip.

  • Erectile difficulty

    Difficulty achieving or maintaining erections, often alongside reduced morning erections.

  • Low mood

    Flat affect, loss of drive, sometimes misread as primary depression.

  • Loss of muscle mass

    Reduced strength and lean mass despite unchanged training and diet.

  • Reduced body hair

    Thinning of beard and body hair over months to years.

  • Decreased bone density

    Fragility fractures or a low T-score on DEXA in men under 70.

  • Cognitive slowing

    Word-finding difficulty, slower processing, poor concentration.

Proper workup before TRT

The tests that must precede a prescription.

A workup that omits pituitary hormones, prostate assessment or haematocrit is not a workup.

  • Two morning total testosterone

    Between 07:00 and 11:00, fasted, on two separate days. Diagnosis requires a repeatably low value, not a single reading.

  • LH and FSH

    Distinguishes primary (testicular) from secondary (hypothalamic or pituitary) hypogonadism.

  • SHBG and calculated free T

    SHBG shifts with age, obesity and thyroid status. Free or bioavailable testosterone clarifies borderline totals.

  • Prolactin

    Raised prolactin points to a pituitary cause and warrants pituitary MRI.

  • HbA1c and lipid profile

    Metabolic screen. Type 2 diabetes and obesity commonly coexist with low testosterone.

  • PSA if over 40

    Baseline prostate-specific antigen and a digital rectal examination before starting.

  • Haematocrit and full blood count

    Baseline before therapy. TRT raises haematocrit and can cause polycythaemia.

  • DEXA scan where indicated

    If osteoporosis is suspected or fragility fracture history is present.

Causes to identify

Primary, secondary and reversible causes.

The cause changes the treatment. Reversible causes should be corrected before committing to lifelong TRT.

  • Primary hypogonadism

    Testicular failure: Klinefelter syndrome, orchitis, trauma, chemotherapy or radiotherapy. LH and FSH are elevated.

  • Secondary hypogonadism

    Hypothalamic or pituitary cause. LH and FSH are inappropriately low or normal alongside low testosterone.

  • Pituitary tumour

    Prolactinoma or non-functioning adenoma. Raised prolactin, visual field defects or headache should prompt MRI.

  • Obstructive sleep apnoea

    Suppresses testosterone and often reverses with CPAP. Screen with STOP-BANG and refer where positive.

  • Obesity and metabolic syndrome

    Weight loss of 10 percent frequently restores testosterone into the normal range without TRT.

  • Medication effects

    Long-term opioids, glucocorticoids, anabolic steroid use and some antidepressants suppress the HPG axis.

  • Chronic disease

    Chronic kidney disease, liver disease, HIV and haemochromatosis all cause functional hypogonadism.

Formulations available in the UK

Gels, injections and buccal preparations.

Choice of formulation is a clinical decision shaped by pharmacokinetics, lifestyle and monitoring practicality.

  • Testogel 50 mg gel

    Daily transdermal gel to shoulders or upper arms. Steady levels, easy to titrate, but risk of transfer to partners or children if skin contact occurs before drying.

  • Tostran 2 percent gel

    Alternative daily gel with a metered pump. Similar profile to Testogel with different vehicle and absorption.

  • Nebido (testosterone undecanoate)

    1000 mg intramuscular injection every 10 to 14 weeks after loading. Stable levels, low peak-to-trough variation, requires clinic visit.

  • Sustanon 250 mg

    Mixed testosterone esters, intramuscular every 2 to 3 weeks. Cheaper but produces peaks and troughs in mood and energy.

  • Buccal Striant

    Rarely used in the UK. Buccal mucoadhesive tablet applied twice daily. Gum irritation limits uptake.

Monitoring schedule

Ongoing checks that make TRT safe.

A TRT prescription without a monitoring plan is a red flag.

  • At 3 months

    Total testosterone (timed to the formulation), haematocrit, PSA if over 40, symptom review and side-effect check.

  • At 6 and 12 months

    Repeat bloods and clinical review. Adjust dose or formulation to keep testosterone in the mid-normal range.

  • Annually thereafter

    Bloods, PSA, haematocrit, LFTs and clinical review. Repeat DEXA at 1 to 2 years if the baseline was abnormal.

  • Prostate surveillance

    Any PSA rise above 1.4 ng/mL in a year, or an absolute value above 4, warrants urological review before continuing.

  • Haematocrit threshold

    If haematocrit exceeds 0.54, hold TRT, investigate, and consider venesection or a lower dose on restart.

Risks and side effects

What to weigh before starting.

The evidence base is strongest for polycythaemia, PSA changes and fertility suppression. Discuss all three before prescribing.

  • Polycythaemia

    The most common adverse effect. Injectables carry a higher risk than gels. Managed by dose reduction, formulation switch or venesection.

  • PSA rise and prostate risk

    TRT does not cause prostate cancer but can unmask existing disease. Baseline PSA and DRE before starting; do not treat men with active prostate cancer.

  • Worsening sleep apnoea

    TRT can worsen untreated OSA. Screen and treat sleep apnoea before or alongside therapy.

  • Subfertility

    Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reduces LH and FSH, and suppresses spermatogenesis. Recovery after stopping is variable.

  • Sperm cryopreservation

    Men who may want biological children should be offered sperm banking before starting, or use hCG or clomiphene as alternatives that preserve fertility.

  • Fluid retention and skin changes

    Mild peripheral oedema, acne and oily skin. Usually settles with dose adjustment.

Cost of private TRT in London

Indicative ranges for the first year.

Firm figures depend on formulation, monitoring frequency and whether workup investigations are already available.

Item Indicative range
Initial consultation and workup £250–£450
TRT medication £45–£120 per month
Monitoring review £150–£300 per review
First-year total £750–£2,400

Where to be seen in London

Providers with a proper workup and monitoring pathway.

A shortlist of UK providers that follow BSSM-compliant protocols.

  • Optimale

    National telehealth-led TRT service with UK-based clinicians and monitoring bundles.

  • Balance My Hormones

    UK online and in-person hormone clinic offering full workup and monitoring.

  • The Men’s Health Clinic

    London andrology-led clinic covering TRT, ED and fertility together.

  • London Andrology

    Consultant urology and andrology clinic with hospital-grade diagnostics.

  • Nuffield Health

    National hospital group offering endocrinology-led hormone review in most cities.

When TRT is not appropriate

Situations where the answer is no, or not yet.

Absolute contraindications and situations where reversible factors must be addressed first.

  • Single low reading

    One low testosterone is not a diagnosis. Repeat morning bloods and consider free testosterone before treating.

  • Active prostate or breast cancer

    Absolute contraindications. TRT is androgen-dependent tissue fuel.

  • Untreated severe sleep apnoea

    Treat the OSA first, or use CPAP concurrently.

  • Planning fatherhood

    Not without sperm banking, or discussion of hCG or clomiphene as fertility-sparing alternatives.

  • Unexplained polycythaemia

    Investigate the polycythaemia first. Do not add an androgen to an unexplained high haematocrit.

  • Severe untreated heart failure

    Fluid retention risk. Optimise cardiac status before considering TRT.

Frequently asked

Common questions about TRT.

  • Why does the NHS often refuse to start TRT?

    NHS thresholds for treatment are conservative and services are stretched. Many GPs and endocrinology clinics will only start TRT when total testosterone is repeatedly well below 8 nmol/L with clear symptoms and a specialist opinion. Borderline cases between 8 and 12 nmol/L are frequently declined or referred back for lifestyle measures first.

  • Gel or injection: which is better?

    Neither is universally better. Gels give stable daily levels and are easy to stop, but carry a small transfer risk to partners or children. Nebido offers steady levels with an injection every 10 to 14 weeks. Sustanon is cheaper but produces peaks and troughs. The right choice depends on lifestyle, family circumstances and how your body responds.

  • Will TRT affect my fertility?

    Yes. Exogenous testosterone suppresses LH and FSH and reduces sperm production. Recovery after stopping is variable and can take months to years, and is not guaranteed. If future fatherhood is a consideration, discuss sperm cryopreservation before starting, or ask about hCG or clomiphene as fertility-sparing alternatives.

  • Does TRT increase prostate cancer risk?

    Current evidence does not show that TRT causes prostate cancer. It can, however, accelerate the growth of an existing prostate cancer. A baseline PSA, digital rectal examination and periodic monitoring are essential, and TRT is contraindicated in men with active prostate cancer.

  • Is TRT covered by private medical insurance?

    Diagnostic workup and consultant fees are often covered with a specialist referral and a clear indication. Ongoing medication and long-term monitoring are frequently excluded and paid privately. Check with your insurer in writing before starting.

  • Is TRT for life?

    Usually yes when the cause is permanent, such as primary testicular failure. In functional cases driven by obesity, sleep apnoea, opioids or reversible pituitary suppression, treating the underlying cause can restore normal testosterone and allow TRT to be stopped.

Speak to a consultant

A workup, a diagnosis and, where appropriate, a prescription.

Send your history and any recent bloods. We match you to a UK andrology or endocrinology consultant who follows BSSM 2022, and set out costs before you commit.

WhatsApp us
Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.

WhatsApp us Reply within 24h · Mon–Fri
Call